Filter
1983
Filtered Results: 1983
Text search:
Economic
burden
of
Tuberculosis
Featured
Recommendations
151
New Publications
569
Language
Document type
No document type
1220
Studies & Reports
408
Guidelines
156
Strategic & Response Plan
92
Manuals
62
Fact sheets
15
Training Material
12
Situation Updates
9
Resource Platforms
5
Infographics
4
Countries / Regions
Global
108
India
81
Kenya
70
Western and Central Europe
65
South Africa
55
Ethiopia
50
Nigeria
45
Zambia
43
Uganda
42
Nepal
39
Africa
39
Tanzania
38
Liberia
37
Malawi
36
Eastern Europe
36
Rwanda
30
Sierra Leone
27
Bangladesh
27
Ghana
26
Latin America and the Carribbean
26
Namibia
25
Asia
24
Myanmar / Burma
24
South–East Asia Region
23
Ukraine
22
Lesotho
21
Cambodia
21
Zimbabwe
15
Indonesia
15
Philippines
13
East and Southern Africa
12
Mozambique
11
Botswana
11
South Sudan
11
Congo, Democratic Republic of
8
Haiti
7
West and Central Africa
7
Russia
7
Pakistan
7
Syria
6
Afghanistan
6
Eastern Europe and Central Asia
6
Colombia
5
Cameroon
5
Senegal
5
Burkina Faso
5
Guinea
5
Venezuela
5
North America
5
Moldova
5
Yemen
5
Somalia
5
Thailand
4
Albania
4
Peru
4
Germany
4
Middle East and North Africa
4
Papua New Guinea
4
Sudan
4
Eswatini/ Swaziland
4
Tajikistan
3
China
3
Laos
3
Armenia
3
Jordan
3
Western Pacific Region
3
Vietnam
3
Brazil
3
North Macedonia
2
Benin
2
Chile
2
Turkmenistan
2
Jamaica
2
Southern Africa
2
Argentina
2
Lebanon
2
Sri Lanka
2
Romania
2
Palestine
2
Georgia
2
Timor Leste/ East Timor
1
Mexico
1
Iran
1
Burundi
1
Mongolia
1
Qatar
1
Bulgaria
1
USA
1
Saudi Arabia
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Bolivia
1
Djibouti
1
Egypt
1
Central African Republic
1
Poland
1
Mali
1
Libya
1
Bhutan
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
822
Public Health
133
Clinical Guidelines
118
Key Resources
64
Women & Child Health
47
Pharmacy & Technologies
16
Capacity Building
13
Annual Report MEDBOX
1
Toolboxes
TB
279
HIV
264
AMR
106
COVID-19
91
Health Financing Toolbox
66
Mental Health
64
Global Health Education
54
Planetary Health
52
NCDs
51
NTDs
37
Rapid Response
30
Caregiver
28
Refugee
25
Disability
23
Conflict
23
Pharmacy
18
Polio
16
Ebola & Marburg
11
Natural Hazards
8
Malaria
5
Cholera
3
Specific Hazards
2
South Sudan
1
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr...
Reporting Period 2010-2011
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners and Policy Makers
Education on the move
Schistosomiasis is widely recognized as a disease that is socially determined. An
understanding of the social and behavioural factors linked to disease transmission and
control should play a vital role in designing policies and strategies for schistosomiasis
prevention and control. To this must b...
October 2018
This publication was produced at the request of the United States Agency for International Development. It was prepared independently by David Lowe, David Hales, Britt Herstad, Billy Pick, Aisuluu Bolotbaeva, and Gulgun Jonboboeva.
Recommendations for a public health approach
HIV/AIDS Programme
Annals of Global Health, 87(1), p.30. DOI: http://doi.org/10.5334/aogh.2647
The report shows that older people are not getting the healthcare treatments they desperately need. The COVID-19 response has disrupted services for non-communicable diseases such as cancer and diabetes, communicable diseases such as malaria, and much-needed services for mental health. Combined with...
The five thematic discussion papers in this collection were prepared by members of the Global Prevention Coalition Steering Group and other experts from various institutions and countries. Contributors are listed in alphabetical order. The five papers are meant to inform country consultations and th...
WHO practical guidelines. 2nd edition
Technical guidance.
This technical guidance aims to inform policy and practice development specifically related to improving the health of older refugees and migrants within the European Union and the larger WHO European Region. Both ageing and migration are in themselves complex multidimensional p...
Schistosomiasis is widely recognized as a disease that is socially determined. An understanding of the social and behavioural factors linked to disease transmission and control should play a vital role in designing policies and strategies for schistosomiasis prevention and control. To this must be a...
An international field study by African and German theologicans and health workers.
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
An ICRC Guidance Document
